Luminex Corporation To Release Fourth Quarter and Full-Year 2019 Results After Market Close On February 10, 2020

AUSTIN, Texas, Jan. 23, 2020 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the fourth quarter and full-year ended December 31, 2019 on Monday, February 10, 2020 after the market close.

The company will host a conference call that day at 5:00 p.m. Eastern Time to discuss operating highlights and financial results.

The conference call will be webcast live and may be accessed at Luminex's Investor Relations website at investor.luminexcorp.com.  The presentation slides will be posted to our Investor Relations website after the market close on February 10, 2020.  Analysts may participate on the conference call by dialing (877) 930-7053 (U.S.) or (253) 336-7290 (outside the U.S.).  The access code is 1593082.  The webcast will be archived for six months on our website using the 'replay' link.

About Luminex Corporation

At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. We accelerate reliable answers while simplifying complexity and deliver certainty with a seamless experience. To learn more about Luminex, please visit us at luminexcorp.com.

Contacts
Harriss Currie
Senior Vice President of Finance and Chief Financial Officer
[email protected]
512-219-8020

Jeff Christensen
Senior Director, Investor Relations
[email protected]
512-249-3033

SOURCE Luminex Corporation